Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0001354488-09-000397
Filing Date
2009-03-31
Accepted
2009-03-31 17:09:37
Documents
8
Period of Report
2008-12-31

Document Format Files

Seq Description Document Type Size
1 10K REPORT cordex10k.htm 10-K 883310
2 AMENDMENT cordex1023.htm EX-10.23 5918
3 AMENDMENT cordex1024.htm EX-10.24 5939
4 STRATEGIC MASTER SERVICES AGREEMENT cordex1025.htm EX-10.25 75587
5 CERTIFICATION cordex311.htm EX-31.1 6532
6 CERTIFICATION cordex312.htm EX-31.2 6003
7 CERTIFICATION cordex321.htm EX-32.1 2744
8 CERTIFICATION cordex322.htm EX-32.2 2682
  Complete submission text file 0001354488-09-000397.txt   990482
Mailing Address 470 NAUTILUS STREET SUITE 300 LA JOLLA CA 92073
Business Address 470 NAUTILUS STREET SUITE 300 LA JOLLA CA 92073 (858) 551-5700
Cordex Pharma, Inc. (Filer) CIK: 0001127842 (see all company filings)

EIN.: 860982792 | State of Incorp.: NV | Fiscal Year End: 1231
Type: 10-K | Act: 34 | File No.: 000-33023 | Film No.: 09720019
SIC: 2836 Biological Products, (No Diagnostic Substances)